Financial Performance - The company's revenue for Q1 2022 was ¥643,577,490.50, a decrease of 34.01% compared to ¥975,222,843.19 in the same period last year[3] - Net profit attributable to shareholders was ¥32,498,869.97, down 9.91% from ¥36,074,414.82 year-on-year[3] - The net profit after deducting non-recurring gains and losses surged by 10,665.15% to ¥39,746,660.40 from ¥369,216.19 in the previous year[3] - The company reported a 49.03% decrease in main business income due to the divestiture of fiber assets[8] - Net profit for Q1 2022 was CNY 32,791,964.27, a decline of 10% from CNY 36,334,858.20 in Q1 2021[21] - Earnings per share for Q1 2022 were CNY 0.04, down from CNY 0.05 in Q1 2021[21] Cash Flow - The net cash flow from operating activities was -¥323,103,011.47, a decline of 263.58% compared to ¥197,519,222.99 last year[3] - Cash inflow from operating activities totaled CNY 750,511,190.57, while cash outflow was CNY 1,073,614,202.04, resulting in a significant cash flow deficit[24] - The net cash flow from investment activities was 761,728,828.43 CNY, compared to a negative cash flow of -197,318,455.24 CNY in the previous period[25] - The total cash inflow from financing activities amounted to 981,994,393.90 CNY, while cash outflow for financing activities was 1,297,818,721.03 CNY, resulting in a net cash flow of -315,824,327.13 CNY[25] - The cash and cash equivalents at the end of the period totaled 255,243,824.48 CNY, an increase from the beginning balance of 132,458,055.32 CNY[25] - The net increase in cash and cash equivalents for the period was 122,785,769.16 CNY, contrasting with a decrease of -269,189,358.79 CNY in the previous period[25] Assets and Liabilities - Total assets decreased by 24.60% to ¥2,882,794,247.05 from ¥3,823,219,194.07 at the end of the previous year[3] - The company's total assets decreased from 3,823,219,194.07 CNY at the beginning of the year to 2,882,794,247.05 CNY at the end of the reporting period[16] - Total current liabilities decreased from 3,455,221,028.57 CNY to 2,520,476,148.47 CNY[17] - The total non-current liabilities decreased from 317,159,022.77 CNY to 278,686,991.58 CNY[17] - Shareholders' equity increased by 51.46% to ¥95,654,591.85 from ¥63,155,721.88 at the end of the previous year[3] Shareholder Information - The total number of common shareholders at the end of the reporting period is 76,083[11] - The largest shareholder, Aoyang Group Co., Ltd., holds 30.31% of shares, totaling 235,349,599 shares, with 66,686,547 shares pledged[12] Business Strategy and Operations - The company is undergoing a strategic business transformation by divesting from chemical fiber operations to focus on the medical health sector[13] - The company is actively pursuing market expansion strategies, particularly in the healthcare sector, as part of its business transformation[13] - The company has ongoing research and development efforts in new products and technologies, although specific details were not disclosed in the report[12] Operating Costs - Operating costs decreased by 32.31% year-on-year, attributed to the reduction in costs from the fiber asset divestiture[9] - Total operating costs for Q1 2022 were CNY 651,936,595.48, down 32.5% from CNY 967,477,741.20 year-over-year[19] Other Financial Metrics - The company experienced a 100% decrease in asset disposal income, as no such income was recorded in the current period[9] - The company reported a credit impairment loss of CNY 41,922,470.58, compared to a gain of CNY 2,650,997.33 in the previous year[21] - The company recorded a loss of CNY 142,691.76 from investment activities, compared to a loss of CNY 119,663.24 in the previous year[21] - The company achieved a cash inflow of CNY 950,803,465.62 from the disposal of fixed assets, a significant increase from CNY 76,177,376.75 in the same period last year[24] Audit and Compliance - The company did not conduct an audit for the first quarter report[27]
澳洋健康(002172) - 2022 Q1 - 季度财报